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Lewin B. Commitment and activation at  Poll I1 pro- 
moters: a tail of protein-protein interactions. Cell 
Ptashne M, Gann AF. Activators and targets. Nature 
These two reviews analyze present concepts on 
gene regulation. Specifically, models of DNA- 
protein and protein-protein interactions are dis- 
cussed. 
Sigel E .  Use of Xenopus oocytes for the functional 
expression of plasma membrane proteins. J Membrane 
Biol 1990;117:201-221. 
This article reviews the use of this method for 
the expression/study of plasma membrane pro- 
teins. 
Sell S .  Is there a liver stem cell? Cancer Res 1990;50: 
This article discusses the problem of the origin 
of hepatocytes and bile duct cells. It proposes that 
this is a periportal stem cell from which transi- 
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HEPATOCELLULAR CARCINOMA 
Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto 
A, Tiollais P, Buendia MA. Frequent activation of 
N-myc genes by hepadnavirus insertion in woodchuck 
liver tumours. Nature 1990;347:294-298. 
EDITOR’S ABSTRACT 
This study is part of an ongoing analysis of wood- 
chuck hepatitis virus integration sites in the host 
genome of hepatocellular carcinomas. The study of 
woodchuck hepatitis virus-DNA integration sites may 
shed light on the oncogenic mechanisms involved in 
cellular transformation and tumor formation. Viral 
integration enhancing cellular proto-oncogene ex- 
pression is one such mechanism and has been well 
documented for oncogenic retroviruses such as mouse 
mammary tumor virus and interleukin-1. By cloning a 
woodchuck hepatitis virus integration site from a 
woodchuck hepatocellular carcinoma the authors 
were able to identify a new member of the myc gene 
family, N-myc-2. Examination of 30 additional wood- 
chuck hepatomas revealed viral integration commonly 
occurred near N-myc loci with an additional five 
woodchuck hepatitis virus integrants near the N-myc-2 
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gene and one viral integrant near N-myc-l. Three of 
these N-myc-2 viral integrations were further eval- 
uated and found to be localized within 200 bp of the 
translation stop codon. This 3’ noncoding region has 
recently been identified as a common site of murine 
leukemia virus integration in virally induced T-cell 
lymphomas and results in increased expression of the 
N-myc gene. Similar mechanisms can be proposed for 
hepatocellular carcinoma formation. Woodchuck hep- 
atitis virus integration near cell-growth related proto- 
oncogenes, such as N-myc, can juxtapose viral en- 
hancer elements and growth-regulatory genes. Virally 
induced overexpression of proto-oncogene messenger 
RNA could result from enhanced transcription or 
increased messenger RNA stability. To search for such 
effects the authors analyzed N-myc-2 RNA levels in 30 
woodchuck hepatitis virus-related hepatomas. In- 
creased levels of N-mycd RNA were found in 18 of 30 
tumors, whereas nontumorous portions of the same 
livers had no detectable N-myc-2 RNA. Taken together 
these findings suggest that woodchuck hepatitis virus 
integration can result in altered N-myc-2 gene ex- 
pression in a significant proportion of woodchuck 
hepatocellular carcinomas. The deregulation of N-myc 
gene expression could result in cellular transformation 
and ultimately tumor formation. Such examples of 
hepadnavirus-specific oncogenic mechanisms lend cre- 
dence to theories of hepatitis B virus-induced tumori- 
genesis and provide models to design molecular inves- 
tigations of human hepatocellular carcinoma for- 
mation. 
COMMENTS 
The association between chronic HBV infection and 
human HCC has been established by epidemiological 
studies. The risk of developing primary HCC is 100-fold 
greater in chronic HBV carriers than in age-matched 
noncarriers (1). Chronic hepatitis B is estimated to affect 
5% of the world’s population (2), making it a major 
oncogenic risk factor. Although this association has been 
known for several years, a mechanism linking chronic 
HBV infection to the initiation of tumor formation has 
not been defined (3). Current theories of virus- 
associated HCC tumorigenesis fall into two categories: 
(a) nonspecific mechanisms, where HBV initiates a 
chronic inflammatory state that leads to unregulated 
hepatocyte proliferation and regeneration, random mu- 
tations and ultimately a transformed phenotype and (b) 
specific virally induced mechanisms such as expression 
of viral oncogenes or transcriptional transactivating 
factors, inactivation of host tumor suppressor genes, 
activation of host proto-oncogenes or mutations of 
host chromosomes such as translocations and gene re- 
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arrangements. Murine and avian oncogenic retroviruses 
induce tumor formation by several of these mechanisms 
and provide models for examining potential molecular 
mechanisms of hepadnavirus tumorigenesis. Previous 
studies have demonstrated that none of the hepadnavi- 
ruses contain oncogenes. Of great interest are the 
reports of viral proteins encoded by the X gene and the 
pre S2lS region that contain transactivating activities. 
These genes can be integrated in a truncated form and 
produce viral-host chimeric RNA transcripts and pro- 
teins that can transcriptionally activate other cellular 
genes (4, 5). One member of the hepadnavirus family, 
woodchuck hepatitis virus (WHV), serves as a particu- 
larly useful model of hepatocarcinogenesis. This virus 
acts as a potent inducer of HCC formation after neonatal 
infection and provides a convenient animal model for 
studying hepadnavirus oncogenesis. The complex repli- 
cation and integration life cycle of hepadnaviruses 
results in random chromosomal insertions of full-length 
and partial viral sequences. Viral integration in the host 
genome is observed almost invariably in hepatoma cells 
and is proposed to be critical to HCC development. This 
report examines WHV integration sites in the host 
genome to search for mechanisms such as proto- 
oncogene activation or tumor suppressor gene inacti- 
vation. 
This paper describes three significant findings re- 
garding N-myc gene expression in WHV-associated 
hepatomas. The authors initially cloned a WHV inte- 
gration site from a single hepatoma that developed in a 
chronically infected woodchuck. Sequencing of the 
viral-host DNA junction revealed the woodchuck ge- 
nomic target sequence had homology with the N-myc 
proto-oncogene. N-myc is a member of the myc oncogene 
family of DNA-binding proteins that includes c-myc, 
N-myc, L-myc and s-myc. These proteins appear to be 
transcriptional activators and play a role in cell growth, 
differentiation and neoplastic transformation. Using 
this woodchuck target sequence as a probe, they 
screened the tumor’s genomic DNA and found two 
subsets of N-myc-related clones. The first subset re- 
vealed an N-myc locus that was organized into three 
exons and was the woodchuck homolog of the human 
and murine N-myc genes. This gene was designated 
N-myc-1. The second locus found (named N-myc-2) was 
an N-myc gene lacking both introns - a structure typical 
of a processed gene or retroposon. The presumed 
mechanism for formation of such “cDNA genes’’ in- 
volves reverse transcription and genomic integration of 
a fully spliced intronless mRNA at  some distant time 
point during the evolution of the woodchuck genome. 
There are numerous examples of such retroposons 
scattered throughout mammalian genomes. Usually 
these processed genes are mutated so they are unable to 
express functional polypeptides. However, the deduced 
amino acid sequence of N-myc-2 contained 454 amino 
acids with 80% homology to N-myc-1 and 78% with the 
human N-myc protein. Functional domains were highly 
conserved between these N-myc proteins, as well sug- 
gesting that N-myc-2 could encode a functional proto- 
oncogene product. Turning to a myc functional assay 
involving cotransfection of primary embryo fibroblasts 
with an activated ras oncogene, it was found that 
N-myc-2 resulted in tumorigenic conversion of these 
primary cells with the same efficiency as c-myc. This is 
the first major finding of this study- identification of an 
intronless “retroposon” myc gene, the woodchuck 
N-myc-2, that encodes a functional oncogene protein. It 
is this gene locus that contained their original WHV 
integration. In this tumor a portion of viral DNA 
containing the WHV enhancer had integrated in the 3’ 
untranslated region of N-myc-2, just 6 bp beyond the 
translational stop codon. This finding suggests a possible 
oncogenic event wherein the WHV enhancer element 
integrates in proximity to N-myc and enhances ex- 
pression of the proto-oncogene product. 
To define the frequency of WHV enhancer insertion 
near N-myc genes the authors surveyed 30 additional 
independent woodchuck hepatomas. Analysis of ge- 
nomic DNA revealed six additional tumors with DNA 
rearrangements of N-myc alleles. Five of these six 
rearrangements were of N-myc-2 and one tumor had a 
rearranged N-myc- 1. Further characterization of these 
N-myc rearrangements revealed the presence of WHV 
sequences in five of six tumors, suggesting viral inte- 
gration sites near the N-myc gene. The viral sequences 
hybridized to a 600 bp WHV probe containing the 
enhancer element. In addition, these integration sites 
were localized in the 3’ untranslated region of N-myc-l 
or N-myc-2 analogous to the original tumor. Two tumors 
were selected for polymerase chain reaction amplifi- 
cation of the N-myc-2-WHV junction sequence. Just as 
the initial tumor had WHV sequences integrated 6 bp 
after the N-myc translation stop signal, these tumors 
had integration occur 18 bp and 176 bp beyond the stop 
codon, respectively. This high frequency (20%) of viral 
integration near N-myc genes led to the second major 
finding of this report. All six tumors containing N-myc- 
associated viral sequences expressed N-myc WHV RNA 
cotranscripts. Four of six tumors had elevated levels of 
these N-myc-related transcripts, suggesting a rela- 
tionship between WHV enhancer integration and in- 
creased expression of N-myc RNAs. 
In addition to DNA rearrangements of N-myc genes in 
WHV-associated hepatomas the authors analyzed 
N-myc RNA expression. The third observation of this 
study showed that 18 of 30 tumors expressed varying 
levels of the nonrearranged 2.3 kb N-myc-2 messenger 
RNA (mRNA), whereas no detectable N-myc-2 mRNA 
was found in nontumorous portions of the same livers. 
Livers of uninfected or WHV-infected woodchucks 
without tumors also contained no N-myc-2 transcripts 
by Northern hybridization. This finding suggests that 
enhanced expression of N-myc-2 RNA is mediated by 
transacting factors produced in a majority of WHV- 
associated hepatomas. In sum, these investigators have 
identified a novel intronless N-myc gene that is func- 
tional in transformation assays and whose expression 
can be induced by WHV infection. Viral infection can 
increase N-myc-2 gene expression by either downstream 
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enhancer insertion or in the absence of N-myc-2 genetic 
rearrangements. 
The initial studies of woodchuck HCC by this group 
involved screening RNA prepared from nine separate 
tumors and adjacent nontumorous liver for overex- 
pression of a panel of 15 oncogenes (6). The only elevated 
oncogene RNA was c-myc, found in three of nine 
hepatomas. Further analysis of these three tumors 
revealed that rearrangements of the c-myc gene had 
occurred in all three tumors. One tumor had a truncated 
c-myc gene joined to a unique cellular sequence of 
unknown function. The two other tumors had inte- 
gration of WHV sequences, including the enhancer 
element, near the c-myc gene (7). One integrant was 90 
bp beyond the coding region’s stop codon and the second 
was 621 bp upstream of c-myc’s exon 1. The current 
study was initiated simply by looking at WHV inte- 
gration sites rather than by looking at tumors selected 
for oncogene overexpression. Amazingly, the authors 
discovered a common integration site in a new member 
of the myc oncogene family, N-myc-2. This report of a 
new functional retroposon oncogene is of interest not 
only because it defines a new member of the myc family 
but also because of its evolutionary interest as a genomic 
“retroelement” or processed gene (8). The authors 
follow this lead by analyzing whether N-my-2 is 
frequently rearranged or overexpressed in HCC. They 
find several tantalizing clues including six other tumors 
with N-myclWHV rearrangements and increased 
N-myc-2 RNA levels in 18 of 30 tumors. The latter 
N-myc-2 transcripts did not contain WHV sequences, 
suggesting enhancement of their expression by viral 
transactivating factors. Three of the tumors with 
N-myc-2 gene rearrangements resulting from WHV 
integration had insertions within 200 bp of the trans- 
lation stop signal. Recent reports of murine retroviruses 
integrating into the same 3’ untranslated region of 
N-myc in T-cell lymphoma and myeloma cells (9, 10) 
suggest that this small region may be an “integration 
hot spot.” A recurring theme of myc oncogene ex- 
pression may be emerging in the woodchuck HCC 
studies. This enhanced expression may be caused by 
WHV enhancer insertion near myc gene loci or by virally 
induced transcriptional activating factors. It must be 
remembered that these oncogene alterations do not 
occur in all tumors. Presumably there are several 
genetic events necessary for HCC formation. Different 
combinations of genetic mutations could contribute to 
tumorigenesis - in some cases certain virally mediated 
changes in myc expression are involved in cellular 
transformation whereas other tumors may contain a 
different set of genetic lesions. 
Do WHV integration events mirror HBV-induced 
carcinogenic events? Obviously the answer is not yet 
known, but recent reports of human HCC containing 
HBV integrations near two growth-related genes 
suggest similar mechanisms may be involved (1 1-13). 
Although a short time ago it appeared that hepadnavirus 
tumorigenesis was most likely the result of nonspecific 
inflammatory and immune responses, the recent spate 
of reports linking viral infection with alteration of 
growth-related genes and their expression creates new- 
found interest in specific viral mechanisms. As is often 
the case in pathophysiological events, perhaps both 
specific and nonspecific mechanisms may be involved in 
HCC formation. Specific combinations of genetic lesions 
may lead to selective growth advantages for certain cells. 
Nonspecific host responses may provide an environment 
for such genetic events to frequently occur, or they may 
prevent selective destruction of such genetically favored 
clones. 
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